On this page
What vitamin K2 is
Vitamin K comes in two main families. K1 (phylloquinone) comes from green leafy vegetables and is mainly used by the liver to make blood-clotting proteins. K2 (menaquinones, written MK-4 to MK-13 by chain length) is made by bacteria and found in fermented foods and some animal foods. The richest source by far is natto, a Japanese fermented soybean dish that's high in MK-7. [1]
There's no established upper limit for vitamin K from food or supplements. The US adequate intake for total vitamin K is 120 mcg/day for men and 90 mcg/day for women. [1]
How it works
Vitamin K activates a group of proteins by adding a chemical group to them (carboxylation). Two matter here. Osteocalcin, made by bone-building cells, helps bind calcium into bone. Matrix Gla protein (MGP), in blood-vessel walls, helps stop calcium depositing in arteries. Without enough vitamin K, both stay partly inactive.
That's the basis for the "calcium goes to bones, not arteries" claim. The mechanism is real, and K2 supplements raise the active forms of these proteins in blood tests. [4] The open question is whether that turns into fewer fractures or less heart disease. Changing a blood marker is not the same as changing an outcome.
Clinical evidence — what the trials show
| Study | Dose | Duration | n | Key finding | Grade |
|---|---|---|---|---|---|
| Knapen et al. (2013) — Osteoporos Int doi:10.1007/s00198-013-2325-6 |
MK-7 180 mcg/day vs placebo | 3 years | 244 | In healthy postmenopausal women, MK-7 significantly reduced the age-related decline in bone density and bone strength. | A |
| Emaus et al. (2010) — Osteoporos Int doi:10.1007/s00198-009-1126-4 |
MK-7 360 mcg/day (natto capsules) vs placebo | 1 year | Early postmenopausal women | No effect on the rate of bone loss. | B |
| Rønn et al. (2021) — Osteoporos Int doi:10.1007/s00198-020-05638-z |
MK-7 375 mcg/day vs placebo, with calcium + D | 3 years | 142 | In women with osteopenia, MK-7 activated more osteocalcin but didn't change bone density, bone turnover markers or bone microarchitecture. | A |
| Knapen et al. (2015) — Thromb Haemost doi:10.1160/TH14-08-0675 |
MK-7 180 mcg/day vs placebo | 3 years | 244 | The same cohort as Knapen 2013: MK-7 improved measures of arterial stiffness. This is a surrogate marker, not heart attacks or strokes. | B |
| Diederichsen et al. (2022), AVADEC — Circulation doi:10.1161/CIRCULATIONAHA.121.057008 |
MK-7 720 mcg + D3 25 mcg/day vs placebo | 2 years | Men 65–74 with aortic valve calcification | Didn't significantly slow the progression of aortic valve calcification, the primary outcome. | A |
A caution on the fracture evidence
An influential 2006 meta-analysis reported that vitamin K (mostly high-dose MK-4 in Japanese trials) strongly reduced fractures. Several of the fracture trials came from a single centre whose data were later found problematic or retracted, and the authors now ask readers to disregard those results. [6] Many K2 marketing claims still trace back to that evidence.
MK-7 vs MK-4
Schurgers and colleagues compared K1 and MK-7 directly. K1 fell by 86% within 4 hours, while MK-7 was still circulating days later. [7] At the microgram doses in Indian D3+K2 products, MK-7 is the form that makes sense. A microgram dose of MK-4 is not what the MK-4 trials tested.
Dose
If you take it
90–200 mcg MK-7 once daily with a meal that contains some fat (vitamin K is fat-soluble). 180 mcg is the dose from the positive 3-year trial. [2] Higher doses (360–375 mcg) weren't better for bone density. [3][4] If your D3+K2 product has 45–55 mcg of K2, that's below the trial dose. It isn't harmful, but it's not the tested amount.
India-specific context
Sold mostly as a D3 add-on
India products
| Product | Price | K2 form / dose | Score | Our take |
|---|---|---|---|---|
| Nutrabay Gold Vitamin K2 MK7 200 mcg | ₹549 / 60ct | MK-7 200 mcg | 7.9 (B) | Closest to the trial dose, with a batch COA published. Best standalone K2. |
| Carbamide Forte Vitamin K2 MK4 + MK7 | ₹499 / 60ct | MK-4 100 mcg + MK-7 100 mcg | 7.5 (B) | NABL COA. The MK-7 part is useful; microgram-dose MK-4 adds little. |
| Thorne Vitamin D/K2 | ₹2,499 / 60ct | MK-4 200 mcg + D3 1,000 IU | 8.6 (A+) | Top-tier manufacturing (NSF Certified), but it uses MK-4, not MK-7. |
| Swisse Omega-3 + D3 + K2 | ₹1,899 / 60ct | Combination | 7.4 (B) | Convenient three-in-one at import pricing. |
| Himalayan Organics Vitamin K2 D3 Omega3 | ₹799 / 60ct | K2 45 mcg | 6.5 (C) | K2 well below the trial dose; EPA+DHA not disclosed. |
Scores and prices come from our product database (2026). For D3+K2 combination products ranked by D3 dose, see Best Vitamin D3+K2 in India.
Safety
Warfarin and acenocoumarol
These blood thinners work by blocking vitamin K, so K2 directly weakens them. In a controlled study, 10–20 mcg of MK-7 daily caused a clinically relevant INR drop in 40–60% of people on acenocoumarol, and 45 mcg lowered group INR by about 40%. [8] Don't start, stop or change K2 on these drugs without your doctor. Acenocoumarol is commonly used in India.
Well tolerated
No adverse effects have been reported from high vitamin K intake in healthy people, which is why no upper limit exists. [1] Newer anticoagulants (apixaban, rivaroxaban, dabigatran) don't act through vitamin K, but tell your doctor about any supplement.
Scoring rubric — full breakdown
1. Evidence quality
One good positive bone trial against two null ones, heart results limited to surrogate markers and a null primary outcome, and the old fracture evidence compromised. The mechanism is solid; the outcome evidence isn't. [2][3][4][5][9][6]
2. Dosage confidence
MK-7's long half-life supports once-daily microgram dosing, and 180 mcg is well tested. Higher doses didn't do better, so there's no reason to exceed about 200 mcg. [7]
3. India market fit
Widely available and usually paired with D3. But it's marketed as essential when it isn't, and many products are dosed below the trials.
4. Safety profile
Very safe for most people, but the warfarin/acenocoumarol interaction is serious, and small doses are enough to trigger it. [8]
5. Label accuracy (tested)
Most labels state the form (MK-7 or MK-4) and dose. Some domestic brands publish COAs. We found no independent Indian testing of K2 content.
References
- 1NIH Office of Dietary Supplements. Vitamin K — Health Professional Fact Sheet. ods.od.nih.gov
- 2Knapen MHJ, Drummen NE, Smit E, Vermeer C, Theuwissen E. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013;24(9):2499–507.doi:10.1007/s00198-013-2325-6
- 3Emaus N, et al. Vitamin K2 supplementation does not influence bone loss in early menopausal women: a randomised double-blind placebo-controlled trial. Osteoporos Int. 2010.doi:10.1007/s00198-009-1126-4
- 4Rønn SH, et al. The effect of vitamin MK-7 on bone mineral density and microarchitecture in postmenopausal women with osteopenia, a 3-year randomized, placebo-controlled clinical trial. Osteoporos Int. 2021;32:185–91.doi:10.1007/s00198-020-05638-z
- 5Knapen MHJ, Braam LAJLM, Drummen NE, Bekers O, Hoeks APG, Vermeer C. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: a double-blind randomised clinical trial. Thromb Haemost. 2015;113(5):1135–44.doi:10.1160/TH14-08-0675
- 6Cockayne S, et al. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166(12):1256–61. See the published notice on problematic/retracted included trials: PMC11845094
- 7Schurgers LJ, et al. Vitamin K–containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109(8):3279–83.doi:10.1182/blood-2006-08-040709
- 8Theuwissen E, et al. Effect of low-dose supplements of menaquinone-7 (vitamin K2) on the stability of oral anticoagulant treatment: dose–response relationship in healthy volunteers. J Thromb Haemost. 2013.doi:10.1111/jth.12203
- 9Diederichsen ACP, et al. Vitamin K2 and D in patients with aortic valve calcification: a randomized double-blinded clinical trial. Circulation. 2022.doi:10.1161/CIRCULATIONAHA.121.057008
Medical note. This page is educational and not a diagnosis. If you have osteoporosis, a doctor can offer treatments with far stronger fracture evidence than any supplement.
Affiliate disclosure. Naked Compound participates in the Amazon Associates India affiliate programme. Some product links earn a small commission at no additional cost to you. Commission does not influence our scores, rankings, or conclusions. Full policy: conflicts-policy